Evommune, Inc. (EVMN) - Net Assets

Latest net assets as of : $- USD

Based on the latest financial reports, Evommune, Inc. (EVMN) has net assets worth $- USD as of .

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Evommune, Inc. - Net Assets Trend (None–None)

This chart illustrates how Evommune, Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Evommune, Inc. (None–None)

The table below shows the annual net assets of Evommune, Inc. from None to None.

Equity Component Analysis

This analysis shows how different components contribute to Evommune, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Evommune, Inc. Competitors by Market Cap

The table below lists competitors of Evommune, Inc. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Evommune, Inc.'s equity between the two most recent reporting periods.

Book Value vs Market Value Analysis

This analysis compares Evommune, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Capital Efficiency Dashboard

This dashboard shows how efficiently Evommune, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Industry Comparison

This section compares Evommune, Inc.'s net assets metrics with peer companies in the Biotechnology industry.